UnknownPhase 2ketamine
Combined Ketamine and eCBT Intervention for PTSD
Sponsored by Queen's University
NCT ID
NCT04771767
Target Enrollment
16 participants
Start Date
2021-08-01
Est. Completion
2024-03-31
About This Study
An open label RCT assessing the efficacy of a combined treatment approach for PTSD, using Ketamine infusions and online Cognitive Behavioural Therapy.
Conditions Studied
Interventions
- •Ketamine
- •Online Trauma-Focused Cognitive Behavioural Therapy
Eligibility
Age:18 Years - 65 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria: * Diagnosis of PTSD by a psychiatrist on the team using the Clinician Administered PTSD Scale (CAPS-5) with a score of at least 50 and a medium presentation. * Patients will have received at least 2 different types of prior treatment, both of which produced less than a 50% reduction in the participant's symptoms. * Participants with hypertension or cardiovascular disease must be receiving stable treatment to participate. * Participants must speak and read English, and will have consistent and reliable access to the internet. * Patients with suicidal ideation will be included. * Patients with a history of substance abuse will be included (except for opioid use disorder). Exclusion Criteria: Hypomanic/manic episodes, bipolar disorder, acute psychosis, opioid use disorder, treatment with Naltrexone, pregnancy, postpartum, breastfeeding, untreated hypertension, cardiovascular disease, ASPD, active homicidal ideation, and general noncompliance with the study protocol.
Study Locations (1)
Queen's University
Kingston, Ontario, Canada